#1 Clinical Trials Search in Europe

Buspirone Hydrochloride

Buspirone Hydrochloride, commonly known as Buspar, is a medication that has been the subject of various clinical trials. While primarily used as an anti-anxiety drug, researchers have been investigating its potential benefits in other areas of health. This article explores the use of Buspirone Hydrochloride in clinical trials, focusing on its effects on anxiety, digestive health, and respiratory function.

Table of Contents

What is Buspirone?

Buspirone hydrochloride, also known by brand names such as Buspar, Buspiron, or Vanspar, is a medication primarily used to treat anxiety disorders[1]. It belongs to a class of drugs called anxiolytics, which are medications designed to reduce anxiety. Unlike some other anti-anxiety medications, buspirone is not related to benzodiazepines or barbiturates, which are known for their sedative effects and potential for dependence[2].

Medical Uses of Buspirone

Buspirone is primarily prescribed for the following conditions:

  • Anxiety Disorders: This is the main use of buspirone. It helps manage symptoms of anxiety, such as worry, nervousness, and tension[1].
  • Gastroparesis: Some studies are investigating the use of buspirone for treating gastroparesis, a condition where the stomach takes too long to empty its contents. Buspirone may help improve symptoms like early satiety (feeling full quickly) and postprandial fullness (feeling overly full after meals)[3].
  • Dyspnea in Cancer Patients: Research has explored the potential of buspirone in reducing shortness of breath (dyspnea) in cancer patients undergoing chemotherapy[4].
  • Esophageal Motility Disorders: Some studies are looking at buspirone’s effects on improving esophageal motility (the movement of food through the esophagus) in patients with dysphagia (difficulty swallowing)[5].
  • Cocaine Dependence: Researchers have investigated buspirone’s potential in preventing relapse in cocaine-dependent adults[6].

How Buspirone Works

Buspirone works differently from many other anti-anxiety medications. It is a serotonin 1A (5-HT1A) receptor agonist, which means it stimulates certain serotonin receptors in the brain[2]. Serotonin is a neurotransmitter (a chemical messenger in the brain) that plays a crucial role in mood regulation. By affecting serotonin, buspirone can help reduce anxiety symptoms.

In addition to its effects on anxiety, buspirone’s action on serotonin receptors may explain its potential benefits in other conditions. For example, in gastroparesis, it may help improve stomach motility. In esophageal disorders, it might enhance the strength of esophageal contractions[3][5].

Dosage and Administration

The dosage of buspirone can vary depending on the condition being treated and the individual patient’s response. Here are some general guidelines based on the clinical trials:

  • For anxiety disorders, a common dosage is 15 mg twice daily, which can be increased to 30 mg daily if needed[1].
  • In studies for gastroparesis and esophageal motility disorders, dosages ranged from 10 mg to 60 mg per day, often divided into multiple doses[3][5].
  • For dyspnea in cancer patients, one study used 10 mg once daily for 3 days, then twice daily for up to 28 days[4].

It’s important to note that buspirone should always be taken as prescribed by your healthcare provider. They will determine the appropriate dosage for your specific condition and may adjust it over time based on your response and any side effects.

Potential Side Effects

Like all medications, buspirone can cause side effects. Common side effects may include:

  • Dizziness
  • Nausea
  • Headache
  • Nervousness or excitement
  • Lightheadedness

Most side effects are mild and tend to decrease over time. However, if you experience any severe or persistent side effects, you should contact your healthcare provider immediately[2].

Ongoing Research and Potential New Uses

Researchers continue to explore new potential uses for buspirone. Some areas of ongoing research include:

  • Spinal Cord Injuries: A study is investigating whether buspirone can improve breathing capacity in individuals with high-level spinal cord injuries[7].
  • Esophageal Disorders: Research is ongoing to determine if buspirone can improve esophageal motility and reduce symptoms in patients with weak or absent esophageal peristalsis (the wave-like muscle contractions that move food through the esophagus)[5].
  • Substance Use Disorders: Studies are exploring buspirone’s potential in preventing relapse in individuals with cocaine dependence[6].

These research areas are still in the experimental stages, and more studies are needed to confirm the effectiveness and safety of buspirone for these conditions. Patients should not use buspirone for these purposes unless directed by a healthcare provider as part of a clinical trial or approved treatment plan.

Aspect Details
Primary Uses Anxiety disorders, Gastroparesis, Esophageal motility disorders, Respiratory issues in cancer patients
Administration Oral tablets, Various dosages (e.g., 10-30 mg daily)
Trial Designs Randomized, Double-blind, Placebo-controlled, Crossover studies
Duration Typically 2-4 weeks, some with additional washout periods
Outcome Measures Symptom severity, Quality of life, Physiological measurements (e.g., esophageal motility, gastric emptying)
Potential Benefits Improved digestive function, Reduced anxiety, Enhanced respiratory function, Better quality of life
Study Populations Patients with anxiety, gastroparesis, esophageal disorders, cancer-related dyspnea, spinal cord injuries

FAQ

  • What is Buspirone Hydrochloride? Buspirone Hydrochloride, also known as Buspar, is a medication primarily used to treat anxiety disorders. It works by affecting certain chemicals in the brain that may become unbalanced and cause anxiety.
  • What conditions are being studied using Buspirone Hydrochloride in clinical trials? Clinical trials are exploring the use of Buspirone Hydrochloride for various conditions, including anxiety, gastroparesis (delayed stomach emptying), esophageal motility disorders, shortness of breath in cancer patients, and spinal cord injuries.
  • How is Buspirone Hydrochloride administered in these trials? In most trials, Buspirone Hydrochloride is administered orally in tablet form. The dosage and frequency vary depending on the specific study and condition being treated.
  • Are there any side effects associated with Buspirone Hydrochloride? While side effects can vary, common ones may include dizziness, headache, nausea, and nervousness. However, the specific trials mentioned here focus more on the potential benefits rather than side effects.
  • How long do these clinical trials typically last? The duration of clinical trials varies. Some studies last for a few weeks, while others may continue for several months. For example, one trial studying gastroparesis symptoms lasted 4 weeks, while another investigating esophageal motility lasted 4 weeks with a 2-week washout period between treatments.

Ongoing Clinical Trials on Buspirone Hydrochloride

  • Study on Reducing Body Temperature in Healthy Volunteers Using Pethidine and Buspirone to Prevent Shivering

    Not recruiting

    1 1
    Investigated drugs:
    Norway

  • Study on the Effects of Buspirone Hydrochloride for Patients with Weak or Absent Esophageal Motility

    Not recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium

Glossary

  • Bioavailability: The extent and rate at which a drug enters the body's circulation to produce an active effect.
  • Gastroparesis: A condition that affects the normal movement of muscles in the stomach, preventing proper stomach emptying.
  • Dysphagia: Difficulty or discomfort in swallowing.
  • Esophageal Motility: The movement of food and liquids down the esophagus (food pipe) into the stomach.
  • High Resolution Impedance Manometry (HRiM): A test that measures pressure and movement in the esophagus to evaluate swallowing function.
  • Placebo: An inactive substance used in clinical trials to compare the effects of a drug against no treatment.
  • Randomized Clinical Trial: A study where participants are randomly assigned to different treatment groups to compare outcomes.
  • Crossover Trial: A type of clinical trial where participants receive all treatments in a specific order, with a washout period between treatments.
  • Washout Period: A period during a clinical trial when participants stop taking the study medication to allow its effects to wear off before starting a new treatment.
  • Quality of Life (QOL): A measure of an individual's overall well-being and ability to function in daily life.

References

  1. https://clinicaltrials.gov/study/NCT00652730
  2. https://clinicaltrials.gov/study/NCT00653419
  3. https://clinicaltrials.gov/study/NCT03587142
  4. https://clinicaltrials.gov/study/NCT00053846
  5. https://clinicaltrials.gov/study/NCT05629325
  6. https://clinicaltrials.gov/study/NCT01641159
  7. https://clinicaltrials.gov/study/NCT05041322